Loading…
AEON Biopharma, Inc. is projected to decline to $0.4289 by 2027, a -11% move from its current price of $0.4831. AEON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.45 | $0.4828 | $0.518 | -0.06% |
| Jul 14 | $0.4368 | $0.4825 | $0.5331 | -0.12% |
| Jul 15 | $0.4269 | $0.4823 | $0.5448 | -0.18% |
| Jul 16 | $0.4187 | $0.482 | $0.5549 | -0.23% |
| Jul 17 | $0.4115 | $0.4817 | $0.5638 | -0.29% |
| Jul 18 | $0.4051 | $0.4814 | $0.572 | -0.35% |
| Jul 19 | $0.3993 | $0.4811 | $0.5797 | -0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3993 | $0.4811 | $0.5797 | -0.41% |
| Week 2 | $0.3682 | $0.4792 | $0.6236 | -0.81% |
| Week 3 | $0.3456 | $0.4772 | $0.659 | -1.22% |
| Week 4 | $0.3274 | $0.4753 | $0.6899 | -1.62% |
| Week 5 | $0.3121 | $0.4733 | $0.718 | -2.02% |
| Week 6 | $0.2987 | $0.4714 | $0.744 | -2.42% |
| Week 7 | $0.2868 | $0.4695 | $0.7686 | -2.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AEON Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, having completed Phase 2 study for the treatment of cervical dystonia and an ongoing Phase 2 study for the treatment of chronic and episodic migraine.
The company also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. It has license agreements with Daewoong Pharmaceutical Co., LTD., and Viatris Inc., and is based in Irvine, California.
AEON Biopharma, Inc., symbol AEON, operates in the Healthcare sector. The current price is $0.5027, the market cap is $13.22M, and it ranks 5063. The price sits near support at $0.503 and below the SMA50 of $0.7711 and SMA200 of $0.9474, suggesting near-term dynamics are nuanced relative to key moving averages.
The 30-day range spans $0.3121 to $0.8097, RSI14 is 20 and sentiment is NEUTRAL, with annualized volatility at 100% indicating high volatility. The long-run price outlook shows potential bullish momentum in later years according to the forecast, with higher average prices projected into 2030 and beyond.
A major floor 37.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 56.7% above — a clean break opens room to run.
A major ceiling 142.2% above — clearing it would confirm fresh momentum.
Key AEON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AEON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6234 | Sell | $0.5879 | Sell |
| MA 10 | $0.6724 | Sell | $0.6377 | Sell |
| MA 20 | $0.6788 | Sell | $0.6762 | Sell |
| MA 50 | $0.7611 | Sell | $0.7581 | Sell |
| MA 100 | $0.9071 | Sell | $0.885 | Sell |
| MA 200 | $0.946 | Sell | $4.66 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 23.63 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -303.68 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -30.20 | Sell |
| Bollinger %B (20,2) | -0.24 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.57 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 16.68 | Buy |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 0.55 | Sell |
| ADX (14) | 21.55 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture remains NEUTRAL, with RSI at 20 indicating oversold conditions and room for price reaction. The price is near the defined support at $0.503, while the SMA50 sits at $0.7711 and the SMA200 at $0.9474, suggesting longer-term resistance above the current level. The stock trades within a 30-day range of $0.3121 to $0.8097, with a resistance level noted at $0.757 and a high level of near-term volatility as reflected in the 100% annualized volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.483 | $0.4831 | $0.5853 | 0% | Neutral | |
| $0.3111 | $0.4289 | $0.6392 | -11% | Neutral | |
| $0.3562 | $0.5218 | $0.8288 | +8% | Neutral | |
| $0.3862 | $0.5959 | $0.9936 | +23% | Bullish | |
| $0.4004 | $0.6476 | $1.12 | +34% | Bullish | |
| $0.367 | $0.6205 | $1.11 | +28% | Bullish | |
| $0.3047 | $0.5374 | $0.9955 | +11% | Neutral | |
| $0.2984 | $0.548 | $1.04 | +13% | Neutral | |
| $0.2793 | $0.5336 | $1.04 | +10% | Neutral | |
| $0.3727 | $0.7402 | $1.48 | +53% | Bullish | |
| $0.3035 | $0.6745 | $1.48 | +40% | Bullish | |
| $0.6463 | $1.44 | $3.30 | +197% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.483 | $0.4831 | $0.5588 | +0.00% |
| August 2026 | $0.3624 | $0.4391 | $0.5543 | -9.10% |
| September 2026 | $0.3727 | $0.458 | $0.5903 | +4.31% |
| October 2026 | $0.3573 | $0.4444 | $0.5827 | -2.97% |
| November 2026 | $0.3287 | $0.4131 | $0.5495 | -7.05% |
| December 2026 | $0.3422 | $0.4343 | $0.5853 | +5.14% |
Click any year to see its month-by-month AEON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AEON is projected to trade between $0.483 and $0.5853, averaging $0.4831 — a potential gain of 0% from today's $0.4831. Price action looks broadly range-bound.
AEON Biopharma, Inc.'s 2027 outlook centres on $0.4289, within a $0.3111 to $0.6392 range. That is -11% versus the projected 2026 average. That marks a -11% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, AEON could reach as high as $0.8288, with a base case around $0.5218 and support toward $0.3562 — roughly +8% from $0.4831. Price action looks broadly range-bound.
Expect AEON to range from $0.3862 to $0.9936 through 2029. The $0.5959 average target implies a +23% move from current prices. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The AEON price prediction for 2030 points to an average of $0.6476 (low $0.4004, high $1.12) — a potential gain of +34% on today's $0.4831. Momentum favours further upside here.
In 2031, AEON is projected to trade between $0.367 and $1.11, averaging $0.6205 — a potential gain of +28% from today's $0.4831. That is -4% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
AEON Biopharma, Inc.'s 2032 outlook centres on $0.5374, within a $0.3047 to $0.9955 range. That is -13% versus the projected 2031 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2033, AEON could reach as high as $1.04, with a base case around $0.548 and support toward $0.2984 — roughly +13% from $0.4831. A consolidation phase looks the most probable path here.
Expect AEON to range from $0.2793 to $1.04 through 2034. The $0.5336 average target implies a +10% move from current prices. That is -3% versus the projected 2033 average. Price action looks broadly range-bound.
The AEON price prediction for 2035 points to an average of $0.7402 (low $0.3727, high $1.48) — a potential gain of +53% on today's $0.4831. Buyers look set to stay in control over this stretch.
In 2040, AEON is projected to trade between $0.3035 and $1.48, averaging $0.6745 — a potential gain of +40% from today's $0.4831. That is -9% versus the projected 2035 average. Momentum favours further upside here.
AEON Biopharma, Inc.'s 2050 outlook centres on $1.44, within a $0.6463 to $3.30 range. That is up +113% on the projected 2040 average. That marks a +197% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in AEON today (≈ 2,069.964811 AEON) could be worth
$2,972.72
+$1,972.72 (+197%) by 2050 · US Dollar
Based on the average projected AEON price of $1.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AEONwould be worth at today's price.
$1,000 invested in AEON on Jul 10, 2025 (≈ 1,162.790678 AEON) would be worth
$561.74
-$438.26 (-43.8%) today · 0.56× · US Dollar
Based on a AEON entry price of $0.86 vs. today's $0.4831.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.715 | $675.66 | -32.4% |
| 1 month ago | $0.71 | $680.42 | -32.0% |
| 3 months ago | $0.84 | $575.12 | -42.5% |
| 6 months ago | $1.1 | $438.78 | -56.1% |
| 1 year ago | $0.86 | $561.74 | -43.8% |
| All time (3.5y) ago | $724.32 | $0.67 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AEON forecast.
Our base-case forecast reaches $0.97 around 2050.
Implied market cap at $0.97: $25.52M
The multi-year forecast shows a gradual path with initial flatness in 2026-2027 and a shift to bullish momentum later. In 2026 the min and avg are both $0.5027 with a max of $0.6114 and ROI of 0%; 2027 features a drop to min $0.3235, avg $0.446, max $0.6649 and negative ROI of -11.3%. The forecast turns positive in 2028 with min $0.3702, avg $0.5424, max $0.8616 and ROI 7.9%, followed by stronger upside in 2029 (min $0.4026, avg $0.6213, max $1.04, ROI 23.6%).
2030 is characterized by an avg of $0.673, a max of $1.17 and ROI 33.9% with bullish sentiment; 2031 shows avg $0.6451 and ROI 28.3%. 2032-2034 project more moderate gains (avg around $0.56-$0.57) with ROI in the low teens. By 2035 the forecast shows a notable lift to avg $0.7721, max $1.54 and ROI 53.6% as sentiment turns bullish.
The 2040 horizon shows avg $0.7009, max $1.54 and ROI 39.4%. By 2050 the projection calls for avg $1.50, max $3.45 and ROI 198.1%, underscoring a strong long-term bullish potential despite near-term volatility and uncertainty.
Tap a question to reveal the answer.
Average price $0.673; max $1.17; min $0.4159; ROI 33.9%; sentiment BULLISH.
Forecasts show a bullish trajectory in the long term with 2030 average around $0.673 and 2050 average around $1.50, and ROI up to 198.1%, but near-term signals include negative ROI of -11.3% in 2027 and the stock’s high volatility (100%).
Yes. The forecast shows a 2030 max of $1.17, a 2040 max of $1.54, and a 2050 max of $3.45.
Current price is $0.5027 and market cap is $13.22M.
RSI14 is 20; SMA50 is $0.7711; SMA200 is $0.9474; 30-day range is $0.3121-$0.8097; support is $0.503; resistance is $0.757; sentiment is NEUTRAL; annualized volatility is 100%.
AEON Biopharma, Inc. Community Discussion
0Share your AEON Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.